EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease

被引:0
|
作者
Juan Diego Alzate
Reed Mullen
Elad Mashiach
Kenneth Bernstein
Fernando De Nigris Vasconcellos
Lauren Rotmann
Assaf Berger
Tanxia Qu
Joshua S. Silverman
John G. Golfinos
Bernadine R. Donahue
Douglas Kondziolka
机构
[1] New York University,Department of Neurological Surgery, NYU Langone Health
[2] New York University,Department of Radiation Oncology, NYU Langone Health
关键词
Non-small cell lung cancer; Epidermal growth factor receptor; Tyrosine kinase inhibitor; Leptomeningeal disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:387 / 396
页数:9
相关论文
共 50 条
  • [1] EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease
    Alzate, Juan Diego
    Mullen, Reed
    Mashiach, Elad
    Bernstein, Kenneth
    Vasconcellos, Fernando De Nigris
    Rotmann, Lauren
    Berger, Assaf
    Qu, Tanxia
    Silverman, Joshua S.
    Golfinos, John G.
    Donahue, Bernadine R.
    Kondziolka, Douglas
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (02) : 387 - 396
  • [2] Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer
    Zhao, Q.
    Deng, L.
    Zhang, Y.
    Zhou, X.
    Li, Y.
    Yu, M.
    Zhou, L.
    Zou, B.
    Liu, Y.
    Lu, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
    Bhandari, Shruti
    Dunlap, Neal
    Kloecker, Goetz
    JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 3230 - 3234
  • [4] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Advancing leptomeningeal metastases treatment in EGFR-mutated non-small cell lung cancer: lessons from the BLOSSOM trial
    Bortolot, Martina
    Huijs, Jarno W. J.
    Brandsma, Dieta
    Compter, Annette
    van Geel, Robin M. J. M.
    Hendriks, Lizza E. L.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (01) : 7 - 13
  • [6] Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series
    Li, Huiying
    Yu, Tingting
    Huang, Mingmin
    Guo, Aibin
    Qian, Xiaoping
    Yin, Zhenyu
    ONCOTARGETS AND THERAPY, 2019, 12 : 7785 - 7790
  • [7] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
    Saboundji, Karima
    Auliac, Jean-Bernard
    Perol, Maurice
    Francois, Geraldine
    Janicot, Henri
    Marcq, Marie
    Dubos-Arvis, Catherine
    Renault, Aldo
    Guisier, Florian
    Odier, Luc
    Gervais, Radj
    Chouaid, Christos
    TARGETED ONCOLOGY, 2018, 13 (04) : 501 - 507
  • [8] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
    Karima Saboundji
    Jean-Bernard Auliac
    Maurice Pérol
    Géraldine François
    Henri Janicot
    Marie Marcq
    Catherine Dubos-Arvis
    Aldo Renault
    Florian Guisier
    Luc Odier
    Radj Gervais
    Christos Chouaïd
    Targeted Oncology, 2018, 13 : 501 - 507
  • [9] Leptomeningeal metastases in EGFR-mutated non-small cell lung carcinoma: Management after tyrosine kinase inhibitors
    Flippot, R.
    Auclin, E.
    Biondani, P.
    Le Rhun, E.
    Planchard, D.
    Caramella, C.
    Le Pechoux, C.
    Lacroix, L.
    Mezquita, L.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S85 - S86
  • [10] Furmonertinib treatment in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, H.
    Wang, L.
    Wu, Y.
    Wu, Y.
    Ma, S.
    Sen, Y.
    Zhen, H.
    Mo, Y.
    Zhang, C.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2023, 34 : S1697 - S1697